Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. - Wikidata - awgldk - TriplyDB

Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.

Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.

http://www.wikidata.org/entity/Q53407917

about

Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma.Targeted renal therapies through microbubbles and ultrasound.Contrast enhanced ultrasound of hepatocellular carcinoma.Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinoma Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.Activity-based cost analysis of contrast-enhanced ultrasonography (CEUS) related to the diagnostic impact in focal liver lesion characterisation.Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial.Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma.Diagnostic imaging of hepatocellular carcinoma: recent progress.Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period.Radiofrequency ablation of liver metastases from colorectal cancer: a literature review Contrast-enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions.Diagnosis and management of giant hepatic hemangioma: the usefulness of contrast-enhanced ultrasonography.Ongoing challenges in the diagnosis of hepatocellular carcinoma.Breakthrough Imaging in Hepatocellular Carcinoma Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.Hepatic malignancies: Correlation between sonographic findings and pathological features.An Image Fusion System for Estimating the Therapeutic Effects of Radiofrequency Ablation on Hepatocellular Carcinoma.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016.Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound.Focal Nodular Hyperplasia of the Liver: Contrast-Enhanced Ultrasonographic Features With Sonazoid.Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.The gross classification of hepatocellular carcinoma: usefulness of contrast-enhanced US.Utility of contrast-enhanced ultrasonography for qualitative imaging of atherosclerosis in Watanabe heritable hyperlipidemic rabbits: initial experimental study.Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index.Contrast-enhanced ultrasound in liver cancer Usefulness of Combination of Imaging Modalities in the Diagnosis of Hepatocellular Carcinoma Using Sonazoid®-Enhanced Ultrasound, Gadolinium Diethylene-Triamine-Pentaacetic Acid-Enhanced Magnetic Resonance Imaging, and Contrast-Enhanced Computed Tom

P2860

Q27005624-08F32CB1-5E3D-4216-98D7-8642CC28E008 Q27012775-B5490A83-5C55-4FE6-A270-09E4D83C681D Q30359316-016358BA-A015-445C-AA24-BF464CCDB559 Q30388235-13FC1F1A-E670-4FF6-80CC-2271E9D56299 Q30455431-360ACADE-4DC9-4FFD-B7D6-48183CA780D0 Q30462259-EEFA5E48-BCD9-4648-93EE-62FECD28E4E8 Q30472126-03C25586-787F-4FAF-90B5-CC6A7F5A4706 Q30472688-D2731D6A-0427-4F8F-B11A-F68549E3BCD7 Q30478156-93822611-F103-4232-BBF1-33BCF7EE7CEE Q30478164-B735E75B-33C4-4A2A-B647-6095985F4971 Q30478166-5FAFD63E-0A60-4C6A-A983-8E81A90594A2 Q30479629-613C420B-66BD-4C44-A942-C5564AA99526 Q33830708-9F52F2EC-9DF0-4CD0-B8A0-033FEF8F3E8C Q34826535-DB6C6797-2199-46D1-9F25-99DECA3B9C36 Q35902261-C53BFE62-B111-473F-88A8-63F1A9CCBA73 Q36637298-8A1DE95E-78AB-42CC-9BBA-A285721AB10B Q37072699-496E2645-3710-47E8-93B8-D87BD155B23F Q37168531-85ABA05D-2755-4904-B62C-DECBC58FC3BC Q37646457-969FF2BF-32F1-430A-81AC-15082572688A Q37972809-38103856-A237-4D05-AD1F-EF4F6FF73FEE Q38054740-31E1BC31-5F1D-4DFA-88AE-BDD158EA083F Q38082982-0F34C68B-1E37-4D17-976D-FD1191C6C8E7 Q38112750-AC07B3F7-9843-4FA9-AB85-6298B015EC22 Q38114077-7D36E5D0-2FD5-4CE5-8227-6C13DB7BF56F Q38646886-0B8F4ADE-A7F7-4FBA-AA90-AC19265341AC Q38969727-8DCC73A1-E4EA-4E26-9A6A-A9AF2154BEE0 Q39167641-3186E243-2BA2-43AE-BBCC-2182504AFEFD Q41126839-C349AC9A-D4B6-45BC-8911-F6D8B18BE47E Q41678118-39FDCA2E-3C71-4FFC-97D5-4EBCD63B3FBA Q41962614-B01A0B29-5808-41AF-908B-12334BD575CE Q43171014-34C20512-E3AD-4619-893C-A7BBC975C0A7 Q48244144-2A061A3A-B7F8-4EFA-8E0A-B34D9288FAF6 Q48265468-919DA607-7D5D-43F4-8253-0890F1F70589 Q50969554-3E99C3ED-0B7C-4DD9-894E-149938283866 Q51541140-F7034BE0-090E-40A7-81D0-F18F2B3A47F2 Q51741309-77F8F8A1-EF87-4FC9-8327-0CA72BFFF088 Q53258247-C9F4434C-4394-4A2B-A943-15BDFDDA22C5 Q53362427-FCC3949A-2391-4EED-AF6F-CECB2B6F4AA0 Q57653509-E0C286A4-4DB7-4E71-8677-F79BF7B982B8 Q57763286-426278AF-1CC5-4EFB-8ED4-50DA0A83DDA3

P2860

Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.

http://www.wikidata.org/entity/Q53407917

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.

@en

Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.

@nl

type

label

Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.

@en

Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.

@nl

prefLabel

Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.

@en

Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.

@nl

P1433

Q53407917-497A4B5F-586A-4D99-B25D-154A31A914B5

P1476

Q53407917-71A9778D-D39B-4CC0-9444-7DC9AC494B46

P2093

Q53407917-116FA99D-BF9D-4979-8973-745B230643D9

Q53407917-19C5E3D3-4373-4A6E-8335-D1AF5EF68FE9

Q53407917-52FAC7A8-0D0F-4D1F-9D38-CA977C4BFAD5

Q53407917-53CA83E8-6C60-4801-8295-673F2FEC8AA6

Q53407917-7082ED52-6702-49F7-BFA9-70259118D509

Q53407917-A70F999C-3287-487E-BC75-17693CC2889B

Q53407917-BA7BAE6B-AE8E-42B9-9D9B-19F70AA8605F

Q53407917-E20CE15D-C20D-41DF-897F-F3037483632F

Q53407917-E2527709-739E-4AEC-8B4D-B564AC961C62

Q53407917-EE1147BD-CF51-4606-8332-5068C8AA489D

P2860

Q53407917-535C4375-F06B-458B-BEEC-8D9F6EF60310

Q53407917-6E2A98FB-6CFF-4D49-9976-C85DADDB60A4

Q53407917-AE221697-322E-4CBA-A010-783CFBE36EF0

Q53407917-C4223EE7-43E5-4815-8081-1F6C2F6315CD

P304

Q53407917-5B246AEA-6348-41D2-B6D7-B73299F758E5

P31

Q53407917-C6137114-4B09-4316-AFF3-7C199E1101F3

P356

Q53407917-25C04666-31B3-4C78-93E4-B73B67512FF4

P478

Q53407917-0D1047A7-794C-4165-B63B-96A6F3F3FF1C

P50

Q53407917-99D56875-6F9F-49DD-BD31-9451A9CD8376

P577

Q53407917-5F9E619D-40CC-4686-9590-D58E2F5FFC4F

P698

Q53407917-48948776-DCFD-4812-AEB5-B16291D3F6D4

P356

P1433

P1476

Differential diagnosis of hepa ...... oped contrast agent, Sonazoid.

@en

P2093

Chie Tatsumi

http://www.w3.org/2001/XMLSchema#string

Hobyung Chung

http://www.w3.org/2001/XMLSchema#string

Kazuomi Ueshima

http://www.w3.org/2001/XMLSchema#string

Kinuyo Hatanaka

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Maekawa

http://www.w3.org/2001/XMLSchema#string

Satoru Hagiwara

http://www.w3.org/2001/XMLSchema#string

Satoshi Kitai

http://www.w3.org/2001/XMLSchema#string

Shunsuke Takahashi

http://www.w3.org/2001/XMLSchema#string

Taisuke Ueda

http://www.w3.org/2001/XMLSchema#string

Tatsuo Inoue

http://www.w3.org/2001/XMLSchema#string

P2860

Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.

Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma.

Color Doppler flow imaging of liver tumors.

Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode.

P304

61-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000122600

http://www.w3.org/2001/XMLSchema#string

P478

51 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18544950

http://www.w3.org/2001/XMLSchema#string